Author's posts
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
Non-English Speakers Face Health Setback If Trump Loosens Language Rules
A rule proposed by the Trump administration would leave patients with limited English proficiency with fewer guarantees of a written notice that free translation services are available. It also would no longer require directions on how patients can report discrimination they experience in a medical setting.
Meth’s Resurgence Spotlights Lack Of Meds To Combat The Addiction
While headlines continue to focus on the nation’s opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.